134 injecting drug users (IDUs) treated at the Department of Infections Diseases of Roslagstull Hospital, Stockholm, were tested for antibodies to human T-lymphotropic virus, types I and II, by means of 2 HTLV-I/II peptide-based enzym immunoassays (EIAs), followed by a whole-virus EIA.
Positive EIA reactions were checked and typed by electrophoretic immunoblotting with native HTLV-I and recombinant HTLV-I and - II proteins. 10 IDU/s were diagnosed as HTLV-II seropositive.
All 10 were of Scandinavian descent.
Mots-clés Pascal : Toxicomanie, Voie intraveineuse, Norvège, Europe, Virose, Infection, Virus HTLV1, Retroviridae, Virus, Virus HTLV2, Diagnostic, Anticorps, Sérum, Exploration immunologique, Homme, Epidémiologie
Mots-clés Pascal anglais : Drug addiction, Intravenous administration, Norway, Europe, Viral disease, Infection, HTLV-I virus, Retroviridae, Virus, HTLV-II virus, Diagnosis, Antibody, Serum, Immunological investigation, Human, Epidemiology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0470365
Code Inist : 002B03D. Création : 199501.